Stay updated on Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The webpage has updated its version from v2.16.2 to v2.16.3 and has added several future dates while removing past dates.
    Difference
    0.5%
    Check dated 2025-06-17T16:55:25.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-10T13:51:29.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-06-03T06:36:48.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-27T05:19:16.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-27T12:37:22.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about a clinical study involving Urothelial Cancer, specifically detailing the drugs Carboplatin and Gemcitabine, and the involvement of collaborators like Merck Sharp & Dohme LLC and Seagen Inc. Additionally, the revision number has been updated to v2.15.0.
    Difference
    13%
    Check dated 2025-04-20T06:38:19.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.